TGTX ▼ -0.7% - TG Therapeutics, Inc. $TGTX TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis 12-OCT-2026 07:31 AM ET